aod9604 igf-1 levels Buy AOD-9604 Research Peptide | hGH Fragment 176-191 AOD-9604 vs. Tesamorelin vs. Semaglutide:

These products are not intended to diagnose, treat, cure, or prevent any disease.

It has been shown to significantly reduce visceral adipose tissue (VAT) in multiple randomized trials (NEJM/phase III evidence

What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects

It remains an investigational peptide used in clinical and research settings outside of formal FDA-approved indications